Tech Times of New York
SEE OTHER BRANDS

Hottest science and technology news from New York

Tech Times of New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.

Press releases published on June 11, 2025

Abivax Announces Results of its June 6, 2025 Annual General Meeting

Abivax Announces Results of its June 6, 2025 Annual General Meeting

Abivax Announces Results of its June 6, 2025 Annual General Meeting PARIS, France, June 11, 2025, 10:00 p.m. CEST – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq – ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused …

ZBIO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Zenas BioPharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

ZBIO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Zenas BioPharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

FTRE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fortrea Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

FTRE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fortrea Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz …

PEPG INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that PepGen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

PEPG INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that PepGen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

Molecular Partners presents positive data from ongoing Phase 1/2a trial of MP0533 in AML at EHA 2025

Molecular Partners presents positive data from ongoing Phase 1/2a trial of MP0533 in AML at EHA 2025

Three of eight evaluable patients with R/R AML responded after cycle 1 in ongoing cohort 8, including 1 patient with ongoing response beyond 6 months Acceptable safety profile across all cohorts, including in cohort 8 with steeper step-up dosing Data …

Attention Long-Term Investors of AppLovin Corporation (NASDAQ: APP); Mercury Systems, Inc. (NASDAQ: MRCY); Monolithic Power Systems, Inc. (NASDAQ: MPWR); and Treace Medical Concepts, Inc. (NASDAQ: TMCI) – Grabar Law Office is Investigating Claims on…

Attention Long-Term Investors of AppLovin Corporation (NASDAQ: APP); Mercury Systems, Inc. (NASDAQ: MRCY); Monolithic Power Systems, Inc. (NASDAQ: MPWR); and Treace Medical Concepts, Inc. (NASDAQ: TMCI) – Grabar Law Office is Investigating Claims on…

PHILADELPHIA, June 11, 2025 (GLOBE NEWSWIRE) -- AppLovin Corporation (NASDAQ: APP): Grabar Law Office is investigating claims on behalf of shareholders of AppLovin Corporation (NASDAQ: APP). The investigation concerns whether certain officers and directors …

Shareholders who lost money on PepGen Inc. (NASDAQ: PEPG) Should Contact Wolf Haldenstein

Shareholders who lost money on PepGen Inc. (NASDAQ: PEPG) Should Contact Wolf Haldenstein

NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- June 11, 2025 - Wolf Haldenstein Adler Freeman …

Winslow Technology Group Named Arctic Wolf’s Northeast Regional Partner of the Year for 2025

Winslow Technology Group Named Arctic Wolf’s Northeast Regional Partner of the Year for 2025

WALTHAM, Mass., June 11, 2025 (GLOBE NEWSWIRE) -- Winslow Technology Group has been named Arctic Wolf’s Northeast Regional Partner of the Year for 2025.  This recognition highlights the company’s exceptional leadership in cybersecurity, outstanding service …

BIOFRONTERA INC. IS NEGOTIATING FUNDAMENTAL CHANGES TO ITS COOPERATION WITH BIOFRONTERA AG

BIOFRONTERA INC. IS NEGOTIATING FUNDAMENTAL CHANGES TO ITS COOPERATION WITH BIOFRONTERA AG

WOBURN, Mass., June 11, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company focused on the development and commercialization of photodynamic therapy (PDT), confirms a disclosure by the Management Board of Biofrontera AG on …

UroGen Pharma Ltd. (URGN) Faces Securities Class Action Amid FDA’s Briefing Document and Subsequent ODAC Vote Against UGN-102– Hagens Berman

UroGen Pharma Ltd. (URGN) Faces Securities Class Action Amid FDA’s Briefing Document and Subsequent ODAC Vote Against UGN-102– Hagens Berman

SAN FRANCISCO, June 11, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit styled Cockrell v. UroGen Pharma Ltd. et al., No. 3:25-cv-06088 (D. N.J.) has been filed and seeks to represent investors who purchased or otherwise acquired UroGen …

SPAR Group, Inc. Responds to False and Disparaging Comments from Former Board Member, Robert G. Brown, Regarding the Company and Its Board

SPAR Group, Inc. Responds to False and Disparaging Comments from Former Board Member, Robert G. Brown, Regarding the Company and Its Board

AUBURN HILLS, Mich., June 11, 2025 (GLOBE NEWSWIRE) -- SPAR Group, Inc. (NASDAQ: SGRP) (“SGRP”, “Spar”, “SPAR Group” or the “Company”), a provider of merchandising, marketing and distribution services, responded today to a press release and filing made by …

Chiesi Group ingår ett globalt licensavtal med Key2Brain AB för utveckling av terapier som passerar blod-hjärnbarriären för behandling av lysosomala upplagringssjukdomar

Chiesi Group ingår ett globalt licensavtal med Key2Brain AB för utveckling av terapier som passerar blod-hjärnbarriären för behandling av lysosomala upplagringssjukdomar

Samarbetet kommer att utnyttja Key2Brains teknik för att ta fram enzymersättningsbehandlingar som passerar blod-hjärnbarriären för lysosomala upplagringssjukdomar Avtalet bygger på ett partnerskap som inleddes 2022 och stödjer fortsatt utveckling som drivs …

Chiesi Group sigla un accordo di licenza mondiale con Key2Brain AB per promuovere terapie che attraversano la barriera ematoencefalica per le malattie da accumulo lisosomiale

Chiesi Group sigla un accordo di licenza mondiale con Key2Brain AB per promuovere terapie che attraversano la barriera ematoencefalica per le malattie da accumulo lisosomiale

La collaborazione sfrutterà la tecnologia di Key2Brain per sviluppare terapie enzimatiche sostitutive in grado di attraversare la barriera ematoencefalica per le malattie da accumulo lisosomiale L'accordo si basa su una partnership avviata nel 2022, a …

New Sleep Apnea Mouth Guard Over the Counter for 2025 - Latest OTC MouthGuard and Mouthpiece for Sleep Apnea OSA from AirSnore

New Sleep Apnea Mouth Guard Over the Counter for 2025 - Latest OTC MouthGuard and Mouthpiece for Sleep Apnea OSA from AirSnore

Glasgow, United Kingdom , June 11, 2025 (GLOBE NEWSWIRE) -- Finding an effective, accessible solution for obstructive sleep apnea (OSA) can be life-changing. While CPAP machines are often prescribed, they’re not always comfortable or convenient for …

INVESTOR DEADLINE MONDAY: Robbins Geller Rudman & Dowd Announces that Zenas BioPharma, Inc. (ZBIO) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

INVESTOR DEADLINE MONDAY: Robbins Geller Rudman & Dowd Announces that Zenas BioPharma, Inc. (ZBIO) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

SAN DIEGO, June 11, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman …

Napco (NSSC) Under Scrutiny: Investor Suit and Sales Slump Shake Investor Confidence – Hagens Berman

Napco (NSSC) Under Scrutiny: Investor Suit and Sales Slump Shake Investor Confidence – Hagens Berman

SAN FRANCISCO, June 11, 2025 (GLOBE NEWSWIRE) -- Shares in Napco Security Technologies, Inc. (NASDAQ: NSSC) are trading down nearly 21% year-to-date, as the security technology company continues to face heightened scrutiny as it navigates both legal and …

E! Entertainment Television Founder Alan Mruvka Launches StorageBlue Music Label

E! Entertainment Television Founder Alan Mruvka Launches StorageBlue Music Label

Media pioneer Alan Mruvka, creator/founder of E! Entertainment Television, has launched StorageBlue Music, a music label blending entertainment with innovation. NEW YORK, NY, UNITED STATES, June 11, 2025 /⁨EINPresswire.com⁩/ -- Media pioneer and …

VNBTC, One of the Best Bitcoin and Dogecoin Cloud Mining Platforms, Poised to Benefit as BTC Set for 15X Growth

VNBTC, One of the Best Bitcoin and Dogecoin Cloud Mining Platforms, Poised to Benefit as BTC Set for 15X Growth

London,UK , June 11, 2025 (GLOBE NEWSWIRE) -- Recently, in a YouTube interview, Akrk Investment’s CEO, Cathie Wood, expressed her belief that the  Bitcoin price will surge to $1.5 million by 2030. This translates to a 15X price increase within 5 years. She …

TSplus Unveils a Redesigned Interface for Remote Support Software

TSplus Unveils a Redesigned Interface for Remote Support Software

PARIS, June 11, 2025 (GLOBE NEWSWIRE) -- TSplus is proud to announce the release of Remote Support 4.1, featuring a completely redesigned interface that elevates the user experience to a new level. This major update reflects our ongoing commitment to …

QuisLex Earns Band 1 Ranking in Chambers and Partners’ NewLaw 2025 Guide

QuisLex Earns Band 1 Ranking in Chambers and Partners’ NewLaw 2025 Guide

NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- QuisLex, a leading alternative legal services provider and pioneer in the industry, announces its inclusion for the 15th consecutive year in the highest level of Chambers and Partners’ annual rankings. QuisLex …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service